MedTrace Logo

Signal Relief Patch in Musculoskeletal Pain

NCT05288114 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-10-28

No results posted yet for this study

Summary

assess the efficacy of the Signal Relief patch for the management of general musculoskeletal pain

Conditions

Interventions

DEVICE

Signal Relief Patch

Eligible subjects will be provided a Signal Relief patch, the instructions for use, and patch placement materials (adhesive, athletic tape, or wrap as applicable for the location of the pain). Subjects will be instructed to use the patch daily for seven days. The patch must be worn constantly except when showing or swimming.

Sponsors & Collaborators

  • Proxima CRO

    collaborator INDUSTRY

  • ITC Imaging, LLC

    collaborator UNKNOWN

  • Signal Relief

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-21
Primary Completion
2022-09-29
Completion
2022-09-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05288114 on ClinicalTrials.gov